Product Name: AMBRISENTAN
Structure:

CAS NO: 177036-94-1
Specification: In-house 99%
Documents: MSDS；Tech Package
Usage: indicated for use in the treatment of pulmonary hypertension.
Supplementary information: was approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency, and designated an orphan drug